Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if rosuvastatin compared to Atorvastatin is effective in
treating ACS by decreasing the ApoB/ApoA-1 ratio and if starting statin within 24 h following
the onset of the first symptoms is beneficial compared to placebo.